Iodocholesterol (131I) API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Iodocholesterol (131I) API 42220-21-3?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Iodocholesterol (131I). You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Iodocholesterol (131I)
- Synonyms:
- Iodocholesterol i-131
- Cas Number:
- 42220-21-3
- DrugBank number:
- DB13797
- Unique Ingredient Identifier:
- C5F4248GPJ
General Description:
Iodocholesterol (131I) is a chemical compound identified by the CAS number 42220-21-3. It is known for its distinct pharmacological properties and applications.
Classification:
Iodocholesterol (131I) belongs to the class of organic compounds known as cholesterols and derivatives. These are compounds containing a 3-hydroxylated cholestane core, classified under the direct parent group Cholesterols and derivatives. This compound is a part of the Organic compounds, falling under the Lipids and lipid-like molecules superclass, and categorized within the Steroids and steroid derivatives class, specifically within the Cholestane steroids subclass.
Categories:
Iodocholesterol (131I) is categorized under the following therapeutic classes: Diagnostic Radiopharmaceuticals, Iodine (131I) Compounds. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Iodocholesterol (131I) is a type of Diagnostic agents
Diagnostic agents are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) used in the field of medical diagnostics. These agents play a vital role in diagnosing various diseases and conditions by aiding in the visualization and identification of specific biomarkers or structures within the body.
Diagnostic agents encompass a wide range of substances, including contrast agents, radiopharmaceuticals, and imaging agents. Contrast agents are commonly used in medical imaging techniques such as X-rays, magnetic resonance imaging (MRI), and computed tomography (CT) scans. They enhance the visibility of certain tissues or organs, allowing healthcare professionals to detect abnormalities more accurately.
Radiopharmaceuticals are another type of diagnostic agent that combines a radioactive component with a pharmaceutical compound. These agents emit radiation that can be detected by specialized imaging equipment, enabling the visualization of metabolic processes and the identification of abnormal cellular activity.
Imaging agents are designed to target specific molecular structures or biomarkers within the body. They can be used to detect and visualize specific proteins, enzymes, or receptors associated with certain diseases or conditions. By targeting these specific biomarkers, imaging agents provide valuable information about the presence, location, and extent of a disease, aiding in diagnosis and treatment planning.
Overall, diagnostic agents are essential tools in modern medicine, facilitating accurate and timely diagnoses. These pharmaceutical APIs enable healthcare professionals to identify and monitor diseases at an early stage, leading to better patient outcomes and improved treatment strategies.
